Bilal Omer

2.5k total citations
44 papers, 1.3k citations indexed

About

Bilal Omer is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Bilal Omer has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 14 papers in Immunology and 11 papers in Epidemiology. Recurrent topics in Bilal Omer's work include CAR-T cell therapy research (20 papers), Immune Cell Function and Interaction (10 papers) and Polyomavirus and related diseases (9 papers). Bilal Omer is often cited by papers focused on CAR-T cell therapy research (20 papers), Immune Cell Function and Interaction (10 papers) and Polyomavirus and related diseases (9 papers). Bilal Omer collaborates with scholars based in United States, Germany and Greece. Bilal Omer's co-authors include Cliona M. Rooney, Stephen Gottschalk, Simone Krebs, Robin Parihar, Leonid S. Metelitsa, Tim Sauer, Kathan Parikh, Haruko Tashiro, Natalia Lapteva and Thomas Shum and has published in prestigious journals such as Blood, The Journal of Immunology and Hepatology.

In The Last Decade

Bilal Omer

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bilal Omer United States 16 877 445 367 326 237 44 1.3k
Ratika Srivastava India 14 313 0.4× 426 1.0× 89 0.2× 280 0.9× 129 0.5× 29 883
Lei Jiang China 23 330 0.4× 157 0.4× 101 0.3× 620 1.9× 44 0.2× 90 1.5k
Sara Baccarini Italy 11 491 0.6× 533 1.2× 71 0.2× 406 1.2× 40 0.2× 11 1.2k
Marie Vétizou France 11 869 1.0× 726 1.6× 84 0.2× 720 2.2× 91 0.4× 20 1.6k
Thomas E. Hansen‐Hagge Germany 19 130 0.1× 532 1.2× 185 0.5× 544 1.7× 116 0.5× 33 1.3k
Anna Diana Italy 18 487 0.6× 153 0.3× 73 0.2× 289 0.9× 24 0.1× 44 995
Mutita Junking Thailand 20 415 0.5× 243 0.5× 69 0.2× 224 0.7× 61 0.3× 51 831
Xueping Wang China 23 428 0.5× 210 0.5× 42 0.1× 353 1.1× 54 0.2× 83 1.3k
Lukas F. Mager Canada 9 547 0.6× 513 1.2× 81 0.2× 773 2.4× 61 0.3× 15 1.5k
Yushe Dang United States 19 651 0.7× 890 2.0× 64 0.2× 343 1.1× 57 0.2× 45 1.3k

Countries citing papers authored by Bilal Omer

Since Specialization
Citations

This map shows the geographic impact of Bilal Omer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilal Omer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilal Omer more than expected).

Fields of papers citing papers by Bilal Omer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bilal Omer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilal Omer. The network helps show where Bilal Omer may publish in the future.

Co-authorship network of co-authors of Bilal Omer

This figure shows the co-authorship network connecting the top 25 collaborators of Bilal Omer. A scholar is included among the top collaborators of Bilal Omer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bilal Omer. Bilal Omer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Puri, Kriti, Luci Corrêa, Brian D. Friend, et al.. (2025). Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors. Pediatric Blood & Cancer. 72(4). e31557–e31557.
2.
Wang, Tao, Meng‐Fen Wu, Thomas Pfeiffer, et al.. (2024). Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors. Cytotherapy. 26(9). 1026–1032.
3.
Pfeiffer, Thomas, Ifigeneia Tzannou, Meng-Fen Wu, et al.. (2023). Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting. Clinical Cancer Research. 29(2). 324–330. 49 indexed citations
4.
Sharma, Sandhya, Tim Sauer, Bilal Omer, et al.. (2023). Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein–Barr Virus-Specific T-Cells. International Journal of Molecular Sciences. 24(21). 15806–15806. 4 indexed citations
5.
Omer, Bilal, Thomas Pfeiffer, Sandhya Sharma, et al.. (2022). A Costimulatory CAR Improves TCR-based Cancer Immunotherapy. Cancer Immunology Research. 10(4). 512–524. 19 indexed citations
6.
Pfeiffer, Thomas, Ifigeneia Tzannou, Swati Naik, et al.. (2021). Allogeneic, Off-the-Shelf Multi-Virus Specific T-Lymphocytes for the Treatment of Virus-Associated Hemorrhagic Cystitis in the Post-HSCT Setting. Transplantation and Cellular Therapy. 27(3). S91–S92. 1 indexed citations
7.
Sauer, Tim, Kathan Parikh, Sandhya Sharma, et al.. (2021). CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity. Blood. 138(4). 318–330. 142 indexed citations
8.
Parihar, Robin, Charlotte Helena Rivas, Bilal Omer, et al.. (2019). NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors. Cancer Immunology Research. 7(3). 363–375. 219 indexed citations
9.
Sauer, Tim, et al.. (2019). CD70-Specific CAR T Cells Have Potent Activity Against Acute Myeloid Leukemia (AML) without HSC Toxicity. Blood. 134(Supplement_1). 1932–1932. 3 indexed citations
10.
Naik, Swati, Ghadir Sasa, Bilal Omer, et al.. (2019). Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without Compromising Engraftment. Biology of Blood and Marrow Transplantation. 25(3). S39–S39. 1 indexed citations
11.
Castillo, Paul, Dimitrios P. Kontoyiannis, Thomas J. Walsh, et al.. (2018). A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae. Molecular Therapy — Methods & Clinical Development. 9. 305–312. 23 indexed citations
12.
Omer, Bilal, Paul Castillo, Haruko Tashiro, et al.. (2018). Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells. Frontiers in Medicine. 5. 343–343. 15 indexed citations
13.
Martinez, Caridad, Ghadir Sasa, Kathryn Leung, et al.. (2018). Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives—A Single-Center Experience, 2008 to 2016. Biology of Blood and Marrow Transplantation. 24(7). 1424–1431. 11 indexed citations
14.
Shum, Thomas, Bilal Omer, Haruko Tashiro, et al.. (2017). Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells. Cancer Discovery. 7(11). 1238–1247. 220 indexed citations
15.
Tanaka, Miyuki, Haruko Tashiro, Bilal Omer, et al.. (2017). Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells. Clinical Cancer Research. 23(14). 3499–3509. 81 indexed citations
16.
Tashiro, Haruko, Tim Sauer, Thomas Shum, et al.. (2017). Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1. Molecular Therapy. 25(9). 2202–2213. 116 indexed citations
17.
18.
19.
Omer, Bilal, et al.. (2007). Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: A double-blind placebo-controlled study. Phytomedicine. 14(2-3). 87–95. 79 indexed citations
20.
Mazzanti, Roberto, Luca Messerini, G Buzzelli, et al.. (1997). Chronic Viral Hepatitis Induced by Hepatitis C But Not Hepatitis B Virus Infection Correlates With Increased Liver Angiogenesis. Hepatology. 25(1). 229–234. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ratika Srivastava Breakdown of academic impact, for papers by Lei Jiang Breakdown of academic impact, for papers by Sara Baccarini Breakdown of academic impact, for papers by Marie Vétizou Breakdown of academic impact, for papers by Thomas E. Hansen‐Hagge Breakdown of academic impact, for papers by Anna Diana Breakdown of academic impact, for papers by Mutita Junking Breakdown of academic impact, for papers by Xueping Wang Breakdown of academic impact, for papers by Lukas F. Mager Breakdown of academic impact, for papers by Yushe Dang
Rankless by CCL
2026